Company Overview of Janus Pharmaceuticals, Inc.
Janus Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in identifying, acquiring, and developing topical prescription products for the treatment of skin infections in North America. Its products include Luliconazole for the treatment of athlete's foot and nail fungus; and WAP-8294A2, a depsipeptide antibiotic for the treatment of skin infections caused by methicillin resistant Staphylococcus aureus and acne. Janus Pharmaceuticals, Inc. was founded in 2004 and is based in Pasadena, California. The company has operations in the United States and Japan.
1111 South Arroyo Parkway
Pasadena, CA 91105
Founded in 2004
Key Executives for Janus Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Janus Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.